Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Arcus Biosciences (RCUS) over the last 3 years, with Q3 2025 value amounting to $3.0 million.

  • Arcus Biosciences' Interest Expenses rose 20000.0% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 30000.0%. This contributed to the annual value of $4.0 million for FY2024, which is 10000.0% up from last year.
  • Per Arcus Biosciences' latest filing, its Interest Expenses stood at $3.0 million for Q3 2025, which was up 20000.0% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Arcus Biosciences' Interest Expenses registered a high of $3.0 million during Q3 2025, and its lowest value of $1.0 million during Q3 2023.
  • For the 3-year period, Arcus Biosciences' Interest Expenses averaged around $1.6 million, with its median value being $1.0 million (2023).
  • Its Interest Expenses has fluctuated over the past 5 years, first changed by 0.0% in 2024, then soared by 20000.0% in 2025.
  • Quarter analysis of 3 years shows Arcus Biosciences' Interest Expenses stood at $1.0 million in 2023, then surged by 100.0% to $2.0 million in 2024, then skyrocketed by 50.0% to $3.0 million in 2025.
  • Its Interest Expenses stands at $3.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.0 million for Q1 2025.